The insurtech revolution is turning out to be far less about disruption than about collaboration—with the insurtech startups bringing improved analytics and user experiences and the traditional market participants bringing consumer trust, solvency and, critically, the ability to comply with industry regulations. But there are regulatory and contractual issues that should be considered when embarking on these collaborations.
Please join Mayer Brown partners Brad Peterson and Stephanie Duchene as they discuss various types of insurtech collaborations, from simple technology licensing to complex platform deals, and the accompanying regulatory and contractual issues to consider in each.
For the full discussion, listen here.
Investing in a US insurance company presents unique concerns to any investor. This is particularly the case if such an investment would result in the investor becoming a ...